← Open Payments lookup

KIKELOMO DAWOTOLA: Open Payments

NPI 1093285504 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$844 in 32 payments from 6 companies in 2025. Trend: 2023 $495 · 2024 $958 · 2025 $844

Food & beverage: $746Education: $98
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.21$558
Alkermes, Inc.4$120
Luye Pharma (USA) Ltd.4$100
Neurocrine BioSciences, Inc.1$31
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$18
ABBVIE INC.1$16

Products named: AUSTEDO XR, ARISTADA, ERZOFRI EXTENDED-RELEASE, INGREZZA, CAPLYTA, VRAYLAR.

Industry payments across TX — which companies pay providers there.